Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 287

1.

Usefulness of cytokeratin 5/6 and AMACR applied as double sequential immunostains for diagnostic assessment of problematic prostate specimens.

Trpkov K, Bartczak-McKay J, Yilmaz A.

Am J Clin Pathol. 2009 Aug;132(2):211-20; quiz 307. doi: 10.1309/AJCPGFJP83IXZEUR.

PMID:
19605815
2.
4.

Double sequential immunostaining for cytokeratin 5/6 and AMACR: an alternative approach in evaluating problematic prostatic specimens.

Trpkov K, Bartczak-McKay J, Yilmaz A.

Histopathology. 2009 Sep;55(3):353-5. doi: 10.1111/j.1365-2559.2009.03347.x. No abstract available.

PMID:
19723151
5.

Using an AMACR (P504S)/34betaE12/p63 cocktail for the detection of small focal prostate carcinoma in needle biopsy specimens.

Jiang Z, Li C, Fischer A, Dresser K, Woda BA.

Am J Clin Pathol. 2005 Feb;123(2):231-6.

PMID:
15842047
6.

Alpha-methylacyl-CoA racemase: a variably sensitive immunohistochemical marker for the diagnosis of small prostate cancer foci on needle biopsy.

Magi-Galluzzi C, Luo J, Isaacs WB, Hicks JL, de Marzo AM, Epstein JI.

Am J Surg Pathol. 2003 Aug;27(8):1128-33.

PMID:
12883245
7.

Prospective evaluation of AMACR (P504S) and basal cell markers in the assessment of routine prostate needle biopsy specimens.

Browne TJ, Hirsch MS, Brodsky G, Welch WR, Loda MF, Rubin MA.

Hum Pathol. 2004 Dec;35(12):1462-8.

PMID:
15619204
8.

Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer.

Luo J, Zha S, Gage WR, Dunn TA, Hicks JL, Bennett CJ, Ewing CM, Platz EA, Ferdinandusse S, Wanders RJ, Trent JM, Isaacs WB, De Marzo AM.

Cancer Res. 2002 Apr 15;62(8):2220-6.

11.

Alpha-methylacyl-CoA racemase (AMACR) in fine-needle aspiration specimens of prostate lesions.

Kaić G, Tomasović-Loncarić C.

Diagn Cytopathol. 2009 Nov;37(11):803-8. doi: 10.1002/dc.21103.

PMID:
19459159
13.
14.

Diagnostic utility of a p63/alpha-methyl-CoA-racemase (p504s) cocktail in atypical foci in the prostate.

Molinié V, Fromont G, Sibony M, Vieillefond A, Vassiliu V, Cochand-Priollet B, Hervé JM, Lebret T, Baglin AC.

Mod Pathol. 2004 Oct;17(10):1180-90.

15.

Reliability of the 34βE12, keratin 5/6, p63, bcl-2, and AMACR in the diagnosis of prostate carcinoma.

Boran C, Kandirali E, Yilmaz F, Serin E, Akyol M.

Urol Oncol. 2011 Nov-Dec;29(6):614-23. doi: 10.1016/j.urolonc.2009.11.013. Epub 2010 Mar 2.

PMID:
20189848
16.
17.
18.

Alpha-methylacyl coenzyme A racemase immunoreactivity in partial atrophy of the prostate.

Adley BP, Yang XJ.

Am J Clin Pathol. 2006 Dec;126(6):849-55.

PMID:
17074684
19.

Immunohistochemistry in diagnostic surgical pathology of the prostate.

Hameed O, Humphrey PA.

Semin Diagn Pathol. 2005 Feb;22(1):88-104. Review.

PMID:
16512601
20.

Alpha-methylacyl-CoA racemase (P504S)/34betaE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy.

Sung MT, Jiang Z, Montironi R, MacLennan GT, Mazzucchelli R, Cheng L.

Hum Pathol. 2007 Feb;38(2):332-41. Epub 2006 Nov 28.

PMID:
17134736

Supplemental Content

Support Center